A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile


BACKGROUND Clostridium difficile-associated disease (CDAD) constitutes a great majority of hospital diarrhea cases in industrialized countries and is induced by two types of large toxin molecules: toxin A (TcdA) and toxin B (TcdB). Development of immunotherapeutic approaches, either active or passive, has seen a resurgence in recent years. Studies have… (More)


6 Figures and Tables

Slides referencing similar topics